It was obvious that the tumor volume in the SPTBN2-knockdown group was significantly reduced compared to the control groups (Fig. 2g, h), and the tumor weight in the SPTBN2 silencing group was also significantly reduced (Fig. 2i). The gene discussed is SPTBN2; the disease is neoplasm.